Thermo Fisher raised its annual profit forecast on strong demand for drug development products, citing improving tariff situation. Quarterly profit beat expectations, with sales in laboratory products segment at $6 billion. CFO to retire in 2026, successor named. Analysts expected segment sales at $5.79 billion, but actual sales surpassed estimates.

Read more at Yahoo Finance: Thermo Fisher flags improving tariff situation, raises annual profit view